Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

Ovid Therapeutics Inc.

GridBrain

GridBrain Sign in

GridSentinel

GridSentinel Sign in

GridAegis

GridAegis Sign in

Key Metrics

Market Snapshot

About

Ovid Therapeutics Inc. is a biopharmaceutical company developing medications for rare neurological disorders. The company focuses on therapies for conditions such as Angelman syndrome, epilepsies, and other rare neurological diseases with significant unmet medical needs. Ovid Therapeutics advances both internally developed programs and in-licensed candidates through clinical development.